Cumberland Pharmaceuticals (CPIX) Institutional Ownership $3.47 +0.07 (+2.06%) Closing price 04:00 PM EasternExtended Trading$3.45 -0.02 (-0.58%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cumberland Pharmaceuticals (NASDAQ:CPIX)CurrentInstitutional OwnershipPercentage15.51%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$2.09MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$1.07M Get CPIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cumberland Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CPIX Institutional Buying and Selling by Quarter Cumberland Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Boothbay Fund Management LLC180,229$604K0.0%-19.5%1.205% 8/15/2025 Bridgeway Capital Management LLC188,355$631K0.0%+2.3%1.259% 8/12/2025 XTX Topco Ltd10,280$34K0.0%N/A0.069% 8/12/2025 Heron Bay Capital Management33,251$111K0.0%N/A0.222% 5/21/2025 Acadian Asset Management LLC49,137$207K0.0%-73.9%0.328% 5/16/2025 Adage Capital Partners GP L.L.C.150,000$634K0.0%N/A1.074% 5/14/2025 Walleye Capital LLC70,419$298K0.0%N/A0.504% 5/14/2025 Berkshire Asset Management LLC PA153,810$692K0.0%N/A1.101% 5/13/2025 Cresset Asset Management LLC19,975$84K0.0%-10.3%0.143% 5/13/2025 Informed Momentum Co LLC71,776$304K0.1%N/A0.514% Get the Latest News and Ratings for CPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 4/29/2025 Bank of New York Mellon Corp72,513$307K0.0%-3.7%0.519% 2/17/2025 Two Sigma Investments LP37,649$89K0.0%+94.3%0.268% 2/17/2025 Bridgeway Capital Management LLC184,155$436K0.0%-35.8%1.312% 2/14/2025 Dimensional Fund Advisors LP272,969$647K0.0%-3.9%1.944% 2/13/2025 Renaissance Technologies LLC507,163$1.20M0.0%-4.0%3.612% 8/9/2024 Dimensional Fund Advisors LP304,109$465K0.0%-15.0%2.143% 10/24/2023 Bank of New York Mellon Corp75,268$142K0.0%N/A0.524% 7/27/2023 B. Riley Wealth Advisors Inc.90,298$133K0.0%N/A0.625% 2/10/2023True Capital Management12,025$27K0.0%N/A0.082% 5/24/2022 M Holdings Securities Inc.10,750$30K0.0%N/A0.073% 2/10/2022 Acadian Asset Management LLC147,294$683K0.0%-9.2%0.995% 2/9/2022 Dimensional Fund Advisors LP652,561$3.05M0.0%-6.3%4.406% 11/15/2021 Berkshire Asset Management LLC PA176,185$472K0.0%+3.1%1.184% 11/15/2021 Dimensional Fund Advisors LP696,654$1.88M0.0%-7.8%4.682% 11/12/2021 Renaissance Technologies LLC664,564$1.78M0.0%-5.3%4.466% 11/9/2021BlackRock Inc.333,051$892K0.0%-15.9%2.238% 8/17/2021 Berkshire Asset Management LLC PA170,830$486K0.0%+3.2%1.135% 8/13/2021 Renaissance Technologies LLC701,463$2.00M0.0%-6.9%4.661% 8/13/2021 California Public Employees Retirement System10,205$29K0.0%-79.3%0.068% 8/13/2021 Ariel Investments LLC12,033$34K0.0%-94.3%0.080% 8/12/2021 Dimensional Fund Advisors LP755,500$2.15M0.0%+2.4%5.020% (Data available from 1/1/2016 forward) CPIX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CPIX shares? During the previous two years, 14 institutional investors and hedge funds held shares of Cumberland Pharmaceuticals. The most heavily invested institutionals were Renaissance Technologies LLC ($1.20M), Berkshire Asset Management LLC PA ($692K), Dimensional Fund Advisors LP ($647K), Adage Capital Partners GP L.L.C. ($634K), Bridgeway Capital Management LLC ($631K), Boothbay Fund Management LLC ($604K), and Bank of New York Mellon Corp ($307K).Learn more on Cumberland Pharmaceuticals' institutional investors. What percentage of Cumberland Pharmaceuticals' stock is owned by institutional investors? 15.51% of Cumberland Pharmaceuticals' stock is owned by institutional investors. Learn more on CPIX's institutional investor holdings. Which institutional investors have been buying Cumberland Pharmaceuticals' stock? Of the 9 institutional investors that purchased Cumberland Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Berkshire Asset Management LLC PA ($153.81K), Adage Capital Partners GP L.L.C. ($150K), Bank of New York Mellon Corp ($75.27K), Informed Momentum Co LLC ($71.78K), Walleye Capital LLC ($70.42K), Heron Bay Capital Management ($33.25K), and Two Sigma Investments LP ($18.27K). How much institutional buying is happening at Cumberland Pharmaceuticals? Institutional investors have bought a total of 512,007 shares in the last 24 months. This purchase volume represents approximately $2.09M in transactions. Which of Cumberland Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold Cumberland Pharmaceuticals stock in the last 24 months: Acadian Asset Management LLC ($139.03K), Bridgeway Capital Management LLC ($102.50K), Boothbay Fund Management LLC ($43.57K), Renaissance Technologies LLC ($21K), Dimensional Fund Advisors LP ($11.04K), Bank of New York Mellon Corp ($2.76K), and Cresset Asset Management LLC ($2.30K). How much institutional selling is happening at Cumberland Pharmaceuticals? Institutional investors have sold a total of 322,188 shares in the last 24 months. This volume of shares sold represents approximately $1.07M in transactions. Related Companies LLY Major Shareholders JNJ Major Shareholders ABBV Major Shareholders MRK Major Shareholders PFE Major Shareholders BMY Major Shareholders ZTS Major Shareholders RPRX Major Shareholders CORT Major Shareholders JAZZ Major Shareholders This page (NASDAQ:CPIX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cumberland Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.